QPPV.COM KNOWLEDGE ASSESSMENT

Dolutegravir: Discovery, Development, Safety and Pharmacovigilance โ€” Knowledge Assessment

Test your understanding of the concepts covered by Dolutegravir: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 An EU pharmacovigilance professional receives a report concerning dolutegravir use in a term neonate at birth weighing 2.2 kg. Which regulatory interpretation is most appropriate based on the article's dated product information?
Question 2 of 10 A reviewer is updating pregnancy-safety communications after larger surveillance datasets became available. Which conclusion is best supported by the article?
Question 3 of 10 A spontaneous report is being reviewed for an event that appears in a postmarketing section of the US label but not in the corresponding EU adverse-reaction table. Which statement is most accurate?
Question 4 of 10 A clinician is considering dolutegravir/lamivudine for a person with HIV and hepatitis B coinfection. Which concern is most relevant?
Question 5 of 10 A spontaneous-report database shows an increasing number of reports of weight gain with dolutegravir. What is the most appropriate interpretation?
Question 6 of 10 A patient taking dolutegravir reports a new increase in metformin-associated adverse effects. Which interaction mechanism is most relevant?
Question 7 of 10 A patient asks why effective dolutegravir treatment does not eradicate HIV. Which explanation best reflects its mechanism?
Question 8 of 10 A company is evaluating whether a reported reaction is listed for Tivicay in the EU. Which method is most appropriate?
Question 9 of 10 A report describes a viral-load increase after a treatment supply interruption, but no genotype is available. Which conclusion is most appropriate?
Question 10 of 10 A patient has virologic failure while taking dolutegravir as part of a combination regimen. Which approach best reflects the principle that the regimen is the exposure?

Select an answer to continue.

QPPV.com